Novo Holdings Launches Portfolio Company Booster Therapeutics to Advance New Class of Small Molecule Proteasome Activator Therapeutics

Novo Holdings United Kingdom Denmark United States of America

View original content:https://www.prnewswire.co.uk/news-releases/novo-holdings-launches-portfolio-company-booster-therapeutics-to-advance-new-class-of-small-molecule-proteasome-activator-therapeutics-302272774.html